PHG Stock Recent News

Philips shares fell sharply on Wednesday as the Dutch healthcare equipment maker again warned on China and again triggered a big drop in its stock price.

Dutch healthcare technology company Philips forecast 2025 comparable sales growth between 1% and 3% on Wednesday after missing market expectations for the final quarter of last year partly due to a double-digit decline in China.

February 19, 2025 Amsterdam, the Netherlands –  Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced proposed Supervisory Board appointments and reappointments, and a proposed Board of Management reappointment. Mr David Pyott (British/American, 1953) will retire from Philips' Supervisory Board at the end of the Annual General Meeting of Shareholders 2025. Mr Pyott joined the Supervisory Board in 2015 and has served three consecutive terms. He has been Chair of the Quality & Regulatory Committee since May 2020. The Supervisory Board will propose to the Annual General Meeting of Shareholders 2025 the appointment of Mr Bob White (American, 1962) as a new member of the Supervisory Board. Following his appointment, Mr White will succeed Mr Pyott as Chair of the Quality & Regulatory Committee.

February 19, 2025 Full Year and Q4 Group performance highlights Sales of EUR 18.0 billion in 2024, comparable sales growth 1%; EUR 5.0 billion in Q4, comparable sales growth 1%, despite double-digit decline in China Comparable order intake increased 1% in 2024; up 2% in Q4, despite double-digit decline in China Income from operations was EUR 529 million in 2024; EUR 199 million in Q4 Adjusted EBITA margin increased 90 basis points to 11.5% of sales in 2024; up 60 basis points to 13.5% in Q4 Net cash flow from operating activities was EUR 1,569 million in 2024; EUR 1,459 million in Q4 Free cash flow was EUR 906 million in 2024; EUR 1,285 million in Q4 Finalized Philips Respironics recall-related medical monitoring and personal injury settlements in US Proposed dividend maintained at EUR 0.85 per share, in shares or cash Increased productivity savings target for 2023-2025 from EUR 2 billion to EUR 2.5 billion, EUR 800 million in 2025 Outlook for 2025 published Roy Jakobs, CEO of Royal Ph

February 10, 2025 Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke  treatment network Amsterdam, the Netherlands and Kyiv, Ukraine – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, in collaboration with the World Bank and Ukraine's Ministry of Health (MOH), today announced a nationwide initiative to modernize stroke and cardiovascular care in Ukraine. The demand for stroke care in Ukraine is nearly doubling, exacerbated by war damage and displaced populations lacking access to timely care.

Phillips 66 shares have underperformed due to weak refining margins, but I remain bullish given the company's diversified business and cost rationalization efforts. Despite a Q4 loss, PSX's midstream segment showed strength, and the acquisition of EPIC NGL should boost future EBITDA. The company plans to return 50% of operating cash flow to investors and aims for $15 billion mid-cycle EBITDA by 2027.

Tend patients can now access Philips Zoom! WhiteSpeed, which combines the power of hydrogen peroxide (HP) and advanced blue LED light technology to achieve brilliant results CAMBRIDGE, Mass.

WASHINGTON , Jan. 28, 2025 /PRNewswire/ -- Bridgefield Capital, a private investment firm specializing in corporate carve-outs and special situations, announced today that it has entered into a definitive agreement to acquire the Philips Emergency Care Business from Royal Philips N.V. (NYSE: PHG).

Not a constructive view on 2025. The CEO's negative tone and a challenging Chinese operating environment support this. Following the Q3 results, the company revised its Q4 sales estimates downward. A pricey valuation and a recovery in sales from H1 to H2 2025 confirmed a neutral view.

January 9, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Jie Xue as Chief Business Leader Precision Diagnosis, and Özlem Fidanci as Chief of International Region, both effective January 1, 2025. Ms. Xue and Ms.